… [10] reported a retrospective analysis revealed DCR for erlotinib administered after … In our
study, The DCR of erlotinib after gefitinib failure was similar to that in Cho’s study. Most patients …

… Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small
cell lung cancer: a retrospective multicenter study. J Thorac Oncol 2011; 6: 148-55. 22. …

… to the first-generation TKI erlotinib or gefitinib in the FLAURA study. In a post hoc analysis,
a … I BLOOM trial as upfront treatment (n = 41) and in a recent retrospective multi-center study …

… We conducted a multicenter retrospective study across three medical centers in Japan.
The study design and methodology was approved by the Institutional Review Board of each …

… According to these results: GEFITINIB, ERLOTINIB and more recently AFATINIB obtained
their registration for the treatment of patients with advanced NSCLC harboring an activating …

… studies are shown in Table 1. Except one global multicenter trial, most of the other studies
… In fact, retrospective studies have shown that patients who were treated with reduced dose …

… retrospectively reviewed the clinical information on patients with NSCLC who were treated
with gefitinib or erlotinib … , placebo-controlled, multicentre study (Iressa Survival Evaluation in …

… Retrospective studies also supported this notion by showing similar PFS between patients …
, this study showed that erlotinib 100 mg/d had similar DCR compared with gefitinib 250 mg/d. …

… They must havec been treated by EGFR-TKI (erlotinib or gefitinib). We retrospectively … 79%
of the patients were treated by erlotinib, 21% by gefitinib, 33 in first line, 1 in 2nd line. For 31/…

… prospective and retrospective studies evaluating the efficacy and safety of gefitinib, erlotinib,
and … In fact, the NEJ003 study is the first to report the efficacy and safety of gefitinib in elderly …